Acute respiratory distress syndrome after convalescent plasma use: Treatment of a patient with Ebola virus disease contracted in Madrid, Spain

The Lancet Respiratory Medicine

Volumn 3, Issue 7, 2015, Pages 554-562

  Mora Rillo, Marta ^a   Arsuaga, Marta ^a   Ramírez Olivencia, Germán ^a   de la Calle, Fernando ^a   Borobia, Alberto M ^a   Sánchez Seco, Paz ^b   Lago, Mar ^a   Figueira, Juan C ^a   Fernández Puntero, Belén ^a   Viejo, Aurora ^a   Negredo, Anabel ^b   Nuñez, Concepción ^a   Flores, Eva ^a   Carcas, Antonio J ^a   Jiménez Yuste, Victor ^a   Lasala, Fátima ^b   García de Lorenzo, Abelardo ^a   Arnalich, Francisco ^a   Arribas, Jose R ^a  

^a UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DIPYRONE; FAVIPIRAVIR; FUROSEMIDE; IBUPROFEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METOCLOPRAMIDE; METRONIDAZOLE; OMEPRAZOLE; ONDANSETRON; OXYGEN; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; VIRUS RNA; AMIDE; ANTIVIRUS AGENT; PYRAZINE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD SAMPLING; BODY FLUID; CASE REPORT; CLERGY; CLINICAL EXAMINATION; CLOSTRIDIUM DIFFICILE INFECTION; COUGHING; DIARRHEA; DRUG MEGADOSE; DYSPEPSIA; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FATIGUE; FEMALE; FEVER; FLUID THERAPY; HEADACHE; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LOADING DRUG DOSE; MACULOPAPULAR RASH; MALAISE; MYALGIA; NURSE; PAIN; PARENTERAL NUTRITION; PATIENT CARE; PATIENT MONITORING; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PROTECTIVE EQUIPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SPAIN; THYROIDITIS; UNIVERSITY HOSPITAL; VIRAL CLEARANCE; VIRUS LOAD; VOMITING; ADVERSE EFFECTS; BLOOD TRANSFUSION; HEMORRHAGIC FEVER, EBOLA; NURSING ASSISTANT; OCCUPATIONAL DISEASES; PATIENT ISOLATION; PLASMA; RESPIRATORY DISTRESS SYNDROME, ADULT; SUPERINFECTION;

ACUTE LUNG INJURY; ADULT; AMIDES; ANTIVIRAL AGENTS; BLOOD TRANSFUSION; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; NURSES' AIDES; OCCUPATIONAL DISEASES; PATIENT ISOLATION; PLASMA; PYRAZINES; RESPIRATORY DISTRESS SYNDROME, ADULT; SPAIN; SUPERINFECTION; VIRAL LOAD;

EID: 84943182977     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00180-0     Document Type: Article

References (25)

1. Frieden TR, Damon I, Bell BP, Kenyon T, Nichol S Ebola 2014-new challenges, new global response and responsibility. N Engl J Med 2014, 371:1177-1180.
2. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014, 371:2402-2409.
3. Parra JM, Salmerón OJ, Velasco M The first case of Ebola virus disease acquired outside Africa. N Engl J Med 2014, 371:2439-2440.
4. Lópaz MA, Amela C, Ordobas M, et al. First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014. Euro Surveill 2015, 20.
5. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks 2014, WHO, World Health Organization, Geneva, (accessed Dec 22, 2014). http://apps.who.int/iris/bitstream/10665/135591/1/WHO_HIS_SDS_2014.8_eng.pdf?ua=1.
6. Chevalier MS, Chung W, Smith J, et al. Ebola virus disease cluster in the United States-Dallas County, Texas, 2014. MMWR Morb Mortal Wkly Rep 2014, 63:1087-1088.
7. Bannister B, Puro V, Fusco FM, Heptonstall J, Ippolito G Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases. Lancet Infect Dis 2009, 9:45-56. for the EUNID Working Group.
8. Vlaar APJ, Juffermans NP Transfusion-related acute lung injury: a clinical review. Lancet 2013, 382:984-994.
9. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014, 371:2092-2100.
10. Bah EI, Lamah M-C, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015, 372:40-47.
11. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A Ebola virus disease in West Africa-clinical manifestations and management. N Engl J Med 2014, 371:2054-2057.
12. Fowler RA, Fletcher T, Fischer WA, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 2014, 190:733-737.
13. Nfon CK, Leung A, Smith G, Embury-Hyatt C, Kobinger G, Weingartl HM Immunopathogenesis of severe acute respiratory disease in Zaire ebolavirus-infected pigs. PLoS One 2013, 8:e61904.
14. Wolf T, Kann G, Becker S, Stephan C, Brodt HR Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet 2015, 385:1428-1435.
15. Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1999, 179(suppl 1):S18-S23. on behalf of the International Scientific and Technical Committee.
16. Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis 1999, 179(suppl 1):S24-S27.
17. Kreil TR Treatment of Ebola virus infection with antibodies from convalescent donors. Emerg Infect Dis 2015, 21:521-523.
18. Furuta Y, Takahashi K, Shiraki K, et al. T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res 2009, 82:95-102.
19. Sissoko D, Anglaret X, Malvy D, et al. Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Conference on Retroviruses and Opportunistic Infections; Seattle, WA, USA; Feb 23-26, 2015. Abstract 103-ALB.
20. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007, 196:S142-S147.
21. Moreau M, Spencer C, Gozalbes JG, et al. Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro Surveill 2015, 20.
22. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by Gram-negative septicemia. N Engl J Med 2014, 371:2394-2401.
23. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis 1999, 179(suppl 1):S28-S35. for the Commission de Lutte contre les Epidémies à Kikwit.
24. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 2014, 371:1481-1495. WHO Ebola Response Team.
25. Protocolo de actuación frente a casos sospechosos de enfermedad por virus ébola (EVE) Anon, (accessed Dec 29, 2014). https://www.msssi.gob.es/Prof.esionales/saludPublica/ccayes/alertasActual/ebola/docs/13102014ProtocoloDeActuacionEVE_CISNS.pdf.